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Introduction: Neonatal mastitis is an inflammatory condition of the breast frequently associated
with Staphylococcus aureus. While Panton–Valentine leucocidin (PVL), a B-pore-forming
cytotoxin, is commonly associated with enhanced virulence in community-acquired methicillin-
resistant S. aureus isolates, this is the first report to our knowledge of neonatal mastitis caused by
PVL-positive S. aureus.
Case presentation: A 20-day-old full-term female neonate presented with bilateral mastitis,
complicated by bilateral abscess formation. PVL toxin-positive S. aureus was cultured from
aspirates of both breasts. All family members, none of whom presented with symptoms of
infection, and, specifically, maternal vaginal samples proved negative for PVL-positive S. aureus.
Successful resolution involved surgical drainage and clindamycin therapy.
Conclusion: While PVL toxin-positive S. aureus has previously been implicated in bovine and
ovine mastitis, there may now be a need for vigilance with respect to human incidence. Due to
PVL-mediated tissue necrosis, breast abscess formation and poor response to conventional
antimicrobial therapy should, perhaps, be a cause for suspicion of PVL-bearing S. aureus and
expediting of appropriate therapy to avoid potential for long-term consequences such as
abnormal breast development.
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Introduction
Staphylococcus aureus is a commensal skin organism, a
major human and veterinary pathogen, and the most
common cause of human mastitis (Osterman & Rahm,
2000; Peton & Le Loir, 2014; Rasigade & Vandenesch,
2014; Uhlemann et al., 2014). As such, considerable
emphasis has been placed on elucidating the mechanisms
by which the virulence of S. aureus strains is mediated
(Rasmussen et al., 2013; Sollid et al., 2014). Amongst these
mechanisms are the horizontal transfer of the chromoso-
mal cassette conferring resistance to methicillin (SCCmec)
(Nubel et al., 2008) and ability to produce toxins such as
(but not limited to) Panton–Valentine leucocidin (PVL)
mediating tissue necrosis (Labandeira-Rey et al., 2007;
Diep et al., 2010).
In the context of maternal and infant health, many studies
have described incidence and transmission of community-
associated and healthcare-associated strains, in addition
to recommended antibiotic regimens, invasive and non-
invasive management, and prevention strategies including
decolonization (Saiman et al., 2003; Fortunov et al., 2007;
Alsubaie et al., 2012; Jahanfar et al., 2013; Sheffield, 2013).
With respect to mastitis specifically, most reports relate to
incidence and treatment of S. aureus maternal infection
(Branch-Elliman et al., 2012; Chick et al., 2012; Iatrakis
et al., 2013; Perez et al., 2013) and, to a lesser degree,
subsequent transmission of infection to (mostly pre-term
and neonatal) infants (Behari et al., 2004; Gastelum et al.,
2005; Kayiran et al., 2014). Mastitis in children is less
common and is largely related to neonates and pubescent/
postpubescent age groups (Faden, 2005). A case series
of neonates demonstrated that mastitis occurred most
commonly in the fourth and fifth weeks of life, althoughAbbreviation: PVL, Panton–Valentine leucocidin.
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age ranged from 12 to 45 days, and that parenteral
antibiotics eradicated causative microorganisms (Stricker
et al., 2005). A larger review of neonatal cases from 2005
to 2011 (in Atlanta, USA) concluded that S. aureus was
the most common cause of mastitis and that no infant
with a positive breast culture had a concordant positive
culture elsewhere (Montague et al., 2013), arguing that
urine, blood and spinal fluid cultures are unnecessary in
otherwise well, afebrile infants with mastitis.
PVL-positive clones are emerging as virulent, multidrug-
resistant S. aureus in Ireland (prevalence of PVL-positive
MRSA increased from 0.2 to 8.8 %, and that of PVL-
positive MSSA decreased from 20 to 2.5 % between 2002
and 2011) (Shore et al., 2014). Despite this, we believe this
report to be the first description of neonatal mastitis
caused by PVL-bearing S. aureus and its successful
treatment and, as such, will make a contribution to the
emerging debate regarding management of neonatal
mastitis (Al Ruwaili & Scolnik, 2012).
Case report
A 20-day-old female infant was admitted to University
Hospital Limerick (UHL) on 16 December 2013. She was
born at 41 weeks gestation via spontaneous vaginal
delivery. At day 7 of life, her mother noted that the baby’s
right breast was swollen and red. When it failed to settle
spontaneously, she brought the baby to her general
practitioner who diagnosed right breast mastitis and
commenced what proved to be ineffective antimicrobial
therapy with oral amoxicillin. The right breast continued
to increase in size and the infant’s condition deteriorated,
with poor feeding, irritability, lethargy and vomiting. The
infant’s parents self-referred to the hospital. On arrival at
UHL, examinations revealed discrete areas of erythema
suggestive of mastitis on both breasts, more marked on the
right. Under the right nipple there was a 4 cm swelling
with underlying yellow–green discoloration of the skin.
The area was warm and tender to touch, with pain elicited
on superficial palpation. There was no obvious pointing
over the right abscess. A 1.5 cm swelling was identified
under the left nipple with no associated topical changes.
The infant was diagnosed with bilateral mastitis, compli-
cated on the right side with early abscess formation. She
was apyrexial.
Haematological investigations demonstrated a normal
white cell count (16.246109 l21), elevated neutrophils
(8.486109 l21), mild thrombocytosis (4276109 l21) and
normal haemoglobin count (14.46109 l21). Renal function
was normal. C-reactive protein was raised at 11 mg l21.
Blood cultures were not completed, while urine was free of
pathogens. A superficial swab of the right breast abscess
resulted in growth of coagulase-negative staphylococci, but
too few to enumerate accurately. Initially, the neonate
was treated conservatively with intravenous flucloxacillin
(220 mg four times per day) and intravenous benzylpenicillin
(220 mg three times per day), but exhibited minimal
improvement. At 3 days, a small area of necrotic skin
developed on the right breast in the periareolar area.
Intravenous benzylpenicillin was discontinued, intravenous
flucloxacillin was continued and oral clindamycin (25 mg
four times per day) was introduced, as (due to increasing
prevalence as described above) there was clinical suspicion
of PVL toxin-mediated staphylococcal infection.
Subsequently, at 5 days, 5 ml aspirate was surgically
removed from the infant’s right breast abscess, which
proved positive for S. aureus resistant to amoxicillin and
gentamicin and sensitive to flucloxacillin, levofloxacin,
linezolid, rifampicin, vancomyin and tetracycline. Intra-
operative examination under anaesthesia confirmed a
contralateral left breast abscess from which 2 ml S. aureus-
positive aspirate was removed.
Post-operative antimicrobial therapy involved oral clin-
damycin and intravenous flucloxacillin. Both isolates of
S. aureus subsequently tested positive for PVL toxin.
Antimicrobial therapy was modified to oral clindamycin
for a further 7 days, at which point full resolution had
been achieved.
Subsequently, staphylococcal protein A (Spa) typing
identified the isolate as being t005 (EMRSA-15) (http://
spa.ridom.de/spa-t005.shtml), which has been reported
mostly in Europe (including the UK and Ireland),
ranked ninth in 2010 with respect to relative incidence
(Grundmann et al., 2010).
Discussion
Reports of neonatal mastitis are relatively uncommon
(Stauffer & Kamat, 2003) but most frequently (ca. 85 %)
caused by S. aureus (Holmes & Zadoks, 2011). As such,
there is some debate regarding best practice in its
management (Al Ruwaili & Scolnik, 2012), but recom-
mended treatment involves antibiotic therapy followed by
surgical incision and drainage or needle aspiration if
medical management fails (Sloan & Evans, 2003).
In this case, we describe the first incidence of PVL-positive
S. aureus-caused neonatal breast abscess. It seems reason-
able that risk factors for neonatal acquisition of PVL-
positive S. aureus would be similar to those for other
S. aureus strains, i.e. ingestion of infected breast milk,
impaired skin integrity, or infection of breast tissue
(engorged due to maternal hormones) via the nipple
(Stauffer & Kamat, 2003). The long-term consequences of
neonatal mastitis and its treatment were reported by
Panteli et al. (2012), whereby development of the breast
was characterized as involving intraductal dilatation,
fibrous elements and calcifications or, where surgical
incision was required, breast asymmetry and significant
reduction in size compared with the uninfected breast. The
emergence of PVL toxin-positive S. aureus (Labandeira-
Rey et al., 2007; Rasmussen et al., 2013; Shore et al., 2014)
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is adding a new perspective to neonatal mastitis incidence
due to its ability for tissue necrosis and the potential
damage that this may cause to infected infants (Hsieh et al.,
1999; Nazir, 2005).
In this case, specifically, the neonate was breastfed
successfully for 4 days postpartum and subsequently
switched to bottle-feeding for convenience. The baby’s
mother did not have any underlying recurrent infective skin
or soft tissue infections. This family had not been washing
domestic items such as towels used for this neonate
separately to those in use for other members of the family.
During the course of the neonatal infection no other family
member presented with signs or symptoms of a PVL-
associated infection. Vaginal carriage of S. aureus is possible;
however, samples obtained from high vaginal and groin
areas proved negative. The potential for zoonosis (Holmes &
Zadoks, 2011) was eliminated as the family did not have a
household pet and did not live on a farm, and there was no
other direct contact with animals. As this was an isolated
incident, environmental (i.e. delivery room and equipment)
and staff screening was considered unnecessary.
The vigilance of the infant’s parents and the relatively
early identification of PVL-positive S. aureus meant that
appropriate targeted (rather than empiric) antimicrobial
therapy resulted in eradication of the pathogen. The
revision of therapy was influenced to no small part by the
availability of aspirated pus, rather than topical swabs,
which underwent on-site molecular and conventional
susceptibility testing, as described elsewhere (O’Connor
et al., 2014), which reduced time to diagnosis by at
least 24 h through avoidance of culture on non-selective
solid media. It is debatable whether non-invasive assess-
ment such as sonography would have been useful in
this case, although its use has been described in
differentiating between neonatal abscesses and mastitis
(Borders et al., 2009).
Conclusion
Neonatal PVL toxin-positive S. aureus mastitis and breast
abscess formation is uncommon but suspicion should arise
with poor response to conventional antimicrobial therapy
for mastitis. There is a need to improve awareness of PVL-
positive S. aureus, particularly among those caring for
neonates, as early diagnosis can prevent complications of
invasive tissue necrosis and potential for long-term con-
sequences such as abnormal breast development. Sending
appropriate samples for testing can expedite diagnosis.
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